logo
  • Home
  • Company
    • Management
    • Board of Directors
    • Governance
    • Medical and Scientific Advisory Board
  • Investors
    • Overview
    • News / Events
    • Shareholder Calls / Presentations
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • News & Media
    • Press Releases
    • Articles
    • Reports
    • Media
    • Photo Gallery
  • Contact
    • Social Media Community Guidelines

Press Releases

Navigation Toggle Navigation
  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Shareholder Calls / Presentations
  • Company Information
  • Financial Information
  • Stock Data
  • SEC Filings
  • Corporate Governance
  • Quick Links
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
  • All News
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • Dec 4, 2015

PharmaCyte Contractor Chamow & Associates to Visit Cell-in-a-Box® Encapsulation Facility in Bangkok, Thailand

  • Nov 24, 2015

PharmaCyte Biotech Provides Link to Orphan Drug Designation for Its Pancreatic Cancer Treatment

  • Nov 19, 2015

PharmaCyte Biotech Announces Appointment of International Diabetes Expert to Scientific Advisory Board

  • Nov 19, 2015

PharmaCyte Biotech Appoints International Diabetes Expert to Its Scientific Advisory Board

  • Nov 17, 2015

PharmaCyte Biotech Obtains Orphan Drug Designation in Europe for Its Pancreatic Cancer Treatment

  • Nov 10, 2015

PharmaCyte Biotech Scientific Advisory Board Member Named Clinical Director of Prestigious Boston Cancer Center

  • Oct 29, 2015

PharmaCyte Biotech Hosts 2nd Annual Meeting of International Diabetes Consortium Developing Novel Treatment for Diabetes

  • Oct 23, 2015

PharmaCyte Biotech Management Interviewed to Discuss Key Aspects of New Pancreatic Cancer Clinical Trial Design

  • Oct 21, 2015

PharmaCyte Biotech Clinical Trial Designed to Expand Standard of Care Therapy for Pancreatic Cancer

  • Oct 19, 2015

PharmaCyte Biotech to Conduct Pancreatic Cancer Clinical Trial in United States

RSS
  • « Previous
  • 1...
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • ...29
  • Next »

Contact Us

PharmaCyte Biotech, Inc.
3960 Howard Hughes Parkway, Suite 500
Las Vegas, Nevada 89169
Office Number: 917.595.2850
Facsimile Number: 917.595.2851
Email: info@PharmaCyte.com

Latest News

  • PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value October 7, 2022
  • PharmaCyte Biotech Reaches Cooperation Agreement with Iroquois Capital August 15, 2022